In a research report issued today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price …
In a research report sent to investors today, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on Aeterna Zentaris (NASDAQ:AEZS) and raised …
Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Celldex Therapeutics (NASDAQ:CLDX) with a $40 price target, following the company’s third-quarter results, posting EPS …
Oppenheimer analyst Akiva Felt maintained an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as a webpage from Johns Hopkins School of Public Health states that …
Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Sarepta Therapeutics (NASDAQ:SRPT) with a $22 price target, which represents a potential upside of …
In a research note issued today, MLV analyst George Zavoico maintained a Buy rating on Geron (NASDAQ:GERN) with a $4.25 price target, following the …
In a research report issued today, Cantor analyst Naved Khan maintained a Buy rating on Priceline.com Inc (NASDAQ:PCLN) with a price target of …
In a research report issued today, Oppenheimer analyst Rick Schafer assigned an Underperform rating on Cirrus Logic (NASDAQ:CRUS). No price target was provided.
Roth Capital analyst Scott Henry reiterated a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) with a price target of $10.00, which represents a potential upside …
In a research report issued Thursday, Wedbush analyst David Nierengarten maintained an Outperform rating on NPS Pharmaceuticals (NASDAQ:NPSP) with a price target of …
